메뉴 건너뛰기




Volumn 879, Issue 23, 2011, Pages 2323-2331

Determination of raloxifene and its glucuronides in human urine by liquid chromatography-tandem mass spectrometry assay

Author keywords

Doping; Glucuronide; LC MS MS; Pharmacokinetics; Raloxifene; Urine

Indexed keywords

ANALYTICAL METHOD; BIOCONVERSION PROCESS; BIOLOGICAL SAMPLES; DETERMINATION COEFFICIENTS; GLUCURONIDES; HUMAN URINE; LC-MS/MS; LIMITS OF QUANTIFICATION; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ASSAYS; POTENTIAL APPLICATIONS; RALOXIFENE; REAL URINE; SIMULTANEOUS DETERMINATIONS; SOLID-PHASE EXTRACTION; STREPTOMYCES SP; URINE; URINE SAMPLE; VALIDATED METHODS;

EID: 79960563050     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2011.06.031     Document Type: Article
Times cited : (24)

References (21)
  • 6
    • 84856074291 scopus 로고    scopus 로고
    • WADA, The World Anti-doping code-The 2011 Prohibited List: International standard, Montreal, Canada.
    • WADA, The World Anti-doping code-The 2011 Prohibited List: International standard, Montreal, Canada, 2011, http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/To_be_effective/WADA_Prohibited_List_2011_EN.pdf.13.01.2011.
    • (2011)
  • 9
    • 84856074292 scopus 로고    scopus 로고
    • U.S.FDA., NDA-020-815, Rockville, MD.
    • U.S.FDA., NDA-020-815, Rockville, MD, 1999, http://www.fda.gov/cder/foi/nda/99/20815S3_Evista.htm.
    • (1999)
  • 16
    • 84856067555 scopus 로고    scopus 로고
    • U.S.FDA., Guidance for Industry, Bioanalytical Method Validation.
    • U.S.FDA., Guidance for Industry, Bioanalytical Method Validation, 2001, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf.
    • (2001)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.